TRIB3 and non-small cell lung carcinoma: To further confirm the role of TRIB3-AKT1 axis in NSCLC progression, we used Pep2–Ae to interrupt the contact between TRIB3 and AKT1 and examined the cell proliferation of integrin αvβ3 positive cells.